Share this page

Clinical outcomes and cost-utility analysis of comprehensive geriatric assessment models in hospitalized frail older patients in Thailand

Suraarunsumrit P, Srinonprasert V, Thavorncharoensap M, Chaikledkaew U, Kongmalai T, Pitiyarn S, Petchthai P, Tankayura K, Kliangda C, McKay G, Thakkinstian A.
BMC Geriatr 2026 Jun 3 , 2026.

Impacts and Economic Burden of Pompe Disease on Patients and Families in Thailand: A Mixed Method Study

Youngkong S; Thavorncharoensap M; Chaikledkaew U; Luangsinsiri C; Tim-Aroon T; Kuptanon C; Sathienkijkanchai A; Rojnueangnit K; Wichajarn K; Boonyawat B; Suphapeetiporn K; Wattanasirichaigoon D.
ClinicoEconomics and Outcomes Research 2026; 18():1-11 , 2026.

A comparison of health-related quality of life between continuous ambulatory peritoneal dialysis and automated peritoneal dialysis in children with stage 5 chronic kidney disease in Thailand: a randomized controlled trial

Thavorncharoensap M, Chaikledkaew U, Youngkong S, Assanatham M, Wisanuyotin S, Chaiyapak T, Pongwilairat N, Srisuwan K, Bhummichitra P, Pruangprasert P, Boonyapapong P, Chongchet N, Khongkhanin U, Vachvanichsanong P, Chartapisak W, Pattaragarn A.
Pediatric Nephrology 2025 Jan 20 , 2025.

Cost-Utility Analysis of Metabolic Bariatric Surgery for Individuals with Obesity in Saudi Arabia

Nagi MA, Turongkaravee S, Almalki ZS, Thavorncharoensap M, Sangroongruangsri S, Chaikledkaew U, Alqahtani AM, AlSharif LS, Alsubaihi IA, Alzarea AI, Alsultan MM.
Clinicoecon Outcomes Res 2025 Jul 23;17:519-533 , 2025.

Determining health-related quality of life among children with malaria in Kenya: does the choice of EQ-5D value set matter?

Okech T, Thavorncharoensap M, Chaikledkaew U, Omondi GP, Nyokabi P, Thumbi SM, Thakkinstian A.
Health Qual Life Outcomes 2025 Nov 15;17:835-848 , 2025.

Economic evaluation of automated peritoneal dialysis among pediatric patients with end state kidney diseases in Thailand

Assanatham M; Youngkong S; Thavorncharoensap M; Pattaragarn A; Chaikledkaew U.
Scientific Reports 2025 Mar 7 , 2025.

Economic evaluation of diagnostic tests for Thai patients with tuberculosis: A dynamic transmission model approach

Chitpim N; Praditsitthikorn N; White LJ; Meeyai A; Jittikoon J; Bunwong K; Youngkong S; Thavorncharoensap M; Mahasirimongkol S; Udomsinprasert W; Chaikledkaew U.
PLoS ONE 2025 Feb 19;73(7):4288-4298 , 2025.

Economic evaluation of dialysis treatment in end-stage renal disease patients with fluid and sodium overload: Evidence from a randomized controlled trial in Thailand

Youngkong S, Yoopetch P, Thavorncharoensap M, Assanatham M, Chaikledkaew U, Sritippayawan S.
PLoS One 2025 Nov 15;17:835-848 , 2025.

The Burden of Obesity in Saudi Arabia: A Real-World Cost-of-Illness Study

Nagi MA, Almalki ZS, Thavorncharoensap M, Sangroongruangsri S, Turongkaravee S, Chaikledkaew U, Alqahtani AM, AlSharif LS, Alsubaihi IA, Alzarea AI, Alsultan MM.
ClinicoEconomics and Outcomes Research 2025 Mar 21;17:233-246 , 2025.

What is the lifetime cost of alcohol consumption? an estimation of economic burden in Thailand

Luangsinsiri C; Thavorncharoensap M; Chaikledkaew U; Pattanaprateep O; Praditsitthikorn N; Sornpaisarn B; Rehm J.
PLoS ONE 2025 Apr-Jun;103(2):130-137 , 2025.

Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey

Youngkong S, Kamolwat P, Wongrot P, Thavorncharoensap M, Chaikledkaew U, Nateniyom S, Pungrassami P, Praditsitthikorn N, Mahasirimongkol S, Jittikoon J, Nishikiori N, Baena IG, Yamanaka T.
Sci Rep 2024 May 16;14(1):11205 , 2024.

Cost Effectiveness of Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: A Systematic Review and Meta-analysis

Wattanasukchai L, Bubphan T, Thavorncharoensap M, Youngkong S, Chaikledkaew U, Thakkinstian A.
American Journal of Cardiovascular Drugs 2024 Nov 21 , 2024.

Cost-effective analysis of hepatitis A vaccination in Kerala state, India

Gurav YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, Gupte MD, Chaikledkaew U, Thakkinstian A, Thavorncharoensap M.
PLoS One 2024 Jun 27;19(6):e0306293 , 2024.

Cost-utility analysis of using high-intensity statin among post-hospitalized acute coronary syndrome patients

Dewi PEN, Thavorncharoensap M, Rahajeng B.
Egypt Heart J 2024 Apr 14;76(1):47 , 2024.

Cost-utility and budget impact analysis of laparoscopic bariatric surgery for obesity with Type II Diabetes Mellitus in Thailand

Noparatayaporn P; Thavorncharoensap M; Chaikledkaew U; Looareesuwan P; Shantavasinkul PC; Sumritpradit P; Thakkinstian A.
PLoS ONE 2024 Nov 8;7(12):3795-3803 , 2024.

Economic evaluation of diagnosis and treatment for latent tuberculosis infection among contacts of pulmonary tuberculosis patients in Thailand

Yoopetch P; Wu O; Jittikoon J; Thavorncharoensap M; Youngkong S; Praditsitthikorn N; Mahasirimongkol S; Anothaisintawee T; Udomsinprasert W; Chaikledkaew U.
Scientific Reports 2024 May 28;15(7):2483-2495 , 2024.

Economic evaluation of tenofovir disoproxil fumarate prophylaxis to prevent mother-to-child transmission of Hepatitis B virus infection: evidence from a lower-middle income country

Nguyen HT; Chaikledkaew U; Hoang MV; Tran VQ; Thavorncharoensap M; Praditsitthikorn N; Tran QD; Thakkinstian A.
BMC Health Services Research 2024 Nov 8;7(12):3795-3803 , 2024.

Impact of the COVID-19 pandemic on time to treatment, treatment patterns and outcomes among patients with acute coronary syndrome in Yogyakarta, Indonesia: a retrospective cohort study

Dewi PEN; Youngkong S; Sunantiwat M; Nathisuwan S; Thavorncharoensap M.
BMJ Open 2024 Oct 14;19:10341-10365 , 2024.

Lifetime costs of alcohol consumption in Thailand: protocol for an incidence-based cost-of-illness study using Markov model

Luangsinsiri C, Thavorncharoensap M, Chaikledkaew U, Pattanaprateep O, Sornpaisarn B, Rehm J.
BMJ Open 2024 Apr 29;14(4):e079829 , 2024.

Treatment seeking experiences of ACS patients in Yogyakarta, Indonesia during COVID-19 pandemic: A qualitative study

Dewi PEN; Sunantiwat M; Thavorncharoensap M; Youngkong S; Nathisuwan S; Rahajeng B.
PLoS ONE 2024; (e0302320):- , 2024.

Economic costs of alcohol consumption in Thailand, 2021

Luangsinsiri C; Youngkong S; Chaikledkaew U; Pattanaprateep O; Thavorncharoensap M.
Global Health Research and Policy 2023; 8(51):- , 2023.

Economic costs of obesity: a systematic review

Nagi MA, Ahmed H, Rezq MAA, Sangroongruangsri S, Chaikledkaew U, Almalki Z, Thavorncharoensap M.
Int J Obes (Lond) 2023 Oct 26 , 2023.

Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis

Yoopetch P, Anothaisintawee T, Gunasekara ADM, Jittikoon J, Udomsinprasert W, Thavorncharoensap M, Youngkong S, Thakkinstian A, Chaikledkaew U.
Sci Rep 2023 Sep 27;13(1):16240 , 2023.

Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds

Gloria MAJ, Thavorncharoensap M, Chaikledkaew U, Youngkong S, Thakkinstian A, Chaiyakunapruk N, Ochalek J, Culyer AJ.
Expert Rev Pharmacoecon Outcomes Res 2023 Dec 19:1-13 , 2023.

Thai stakeholders' awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative study

Worakunphanich W, Suwankesawong W, Youngkong S, Thavorncharoensap M, Anderson C, Toh L.S.
International Journal of Clinical Pharmacy , 2023.

A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North Africa

Nagi MA, Dewi PEN, Thavorncharoensap M, Sangroongruangsri S.
Applied Health Economics and Health Policy 2022 May;20(3):315-335 , 2022.

A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer

Katanyoo K, Thavorncharoensap M, Chaikledkaew U, Riewpaiboon A.
Expert Review of Pharmacoeconomics and Outcomes Research 2022 Jan;22(1):107-117 , 2022.

Acceptance and willingness to pay under the different COVID-19 vaccines: A contingent valuation method

Prasert V, Thavorncharoensap M, Vatcharavongvan P.
Res Social Adm Pharm 2022 Nov;18(11):3911-3919 , 2022.

Comparative efficacy and safety of pharmacologic interventions to prevent mother-to-child transmissionย of hepatitis B virus: a systematic reviewย and network meta-analysis

Nguyen HT, Thavorncharoensap M, Phung TL, Anothaisintawee T, Chaikledkaew U, Sobhonslidsuk A, Talungchit P, Chaiyakunapruk N, Attia J, McKay GJ, Thakkinstian A.
Am J Obstet Gynecol 2022 Aug;227(2):163-172 , 2022.

Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries

Worakunphanich W, Youngkong S, Suwankesawong W, Anderson C, Thavorncharoensap M.
International Journal of Environmental Research and Public Health 2022 May;43(9-10):939-954 , 2022.

Correction to: Exploration of a cultural-adaptation of the EQ-5D for Thai population: A 'bolt-on' experiment (Quality of Life Research, (2019), 28, 5, (1207-1215), 10.1007/s11136-018-2072-4)

Kangwanrattanakul K, Gross CR, Sunantiwat M, Thavorncharoensap M.
Quality of Life Research 2022 Apr;31(4):1267-1268 , 2022.

Does health economics research align with the disease burden in the Middle East and North Africa region? A systematic review of economic evaluation studies on public health interventions

Nagi MA, Rezq MAA, Sangroongruangsri S, Thavorncharoensap M, Dewi PEN.
Glob Health Res Policy 2022 Jan;22(1):107-117 , 2022.

Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi

Niyibitegeka F, Thavorncharoensap M, Riewpaiboon A, Youngkong S.
Appl Health Econ Health Policy 2022 Sep;20(5):707-716 , 2022.

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment

Yoopetch P, Chitpim N, Jittikoon J, Udomsinprasert W, Thavorncharoensap M, Youngkong S, Praditsitthikorn N, Mahasirimongkol S, Chaikledkaew U.
International Journal of Environmental Research and Public Health 2022 May;43(9-10):939-954 , 2022.

Economic burden on people living with HIV who attend self-help groups in Yangon, Myanmar

Aung HNY, Riewpaiboon A, Sunantiwat M, Thavorncharoensap M, Hone S.
Health and Social Care in the Community 2022 Jul;30(4):1530-1540 , 2022.

Factors affecting health-related quality of life of HIV-infected key population in Myanmar

Naing T, Thavorncharoensap M, Riewpaiboon A, Oo HN, Aung MS.
AIDS Care 2022 Aug;34(8):974-981 , 2022.

Priority setting of vaccine introduction in Bangladesh: A multicriteria decision analysis study

Haider MS, Youngkong S, Thavorncharoensap M, Thokala P.
BMJ Open 2022 May 23 , 2022.

A systematic review of demand-side methods of estimating the societal monetary value of health gain

Gloria MAJ, Thavorncharoensap M*, Chaikledkaew U, Youngkong S, Thakkinstian A, Culyer AJ..
Value in Health 2021; 24(10): 1423-1434., 2021.

A systematic review of economic evaluations of vaccines in Middle East and North Africa countries: is existing evidence good enough to support policy decision-making?

Nagi MA, Luangsinsiri C, Thavorncharoensap M*..
Expert Review of Pharmacoeconomics and Outcomes Research 2021; 21(6): 1159-1178., 2021.

Cost of premature mortality attributable to smoking in the Middle East and North Africa

Nagi M, Riewpaiboon A, Thavorncharoensap M*..
Eastern Mediterranean Health Journal 2021; 27(10): 974-983., 2021.

Cost-effectiveness analysis of diagnostic tests for para-aortic lymph node detection in locally advanced cervical cancer

Katanyoo K, Chaikledkaew U*, Thavorncharoensap M, Riewpaiboon A..
Clinicoecon Outcomes Res 2021; 13: 943-955., 2021.

Cost-utility analysis of dapagliflozin compared to sulfonylureas for type 2 diabetes as second-line treatment in indian healthcare payer’s perspective

Bagepally BS, Chaikledkaew U*, Youngkong S, Anothaisintawee T, Thavorncharoensap M, Dejthevaporn C, Thakkinstian A..
ClinicoEconomics and Outcomes Research 2021; 13: 897-907., 2021.

Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi

Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M..
Vaccine 2021; 39(8) :1272-1282., 2021.

Economic burden of childhood diarrhea in Burundi

Niyibitegeka F, Riewpaiboon A*, Youngkong S, Thavorncharoensap M..
Global Health Research and Policy 2021; 6(1): 13., 2021.

Economic evaluation of population-based type 2 diabetes mellitus screening at different healthcare settings in Vietnam

Toi PL, Wu O, Thavorncharoensap M, Srinonprasert V, Anothaisintawee T, Thakkinstian A, Phuong NK, Chaikledkaew U*..
PLoS One 2021; 16(12): e0261231., 2021.

Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand

Rochanathimoke O, Riewpaiboon A, Praditsitthikorn N, Tharmaphornpilas P, Jiamsiri S, Thavorncharoensap M, Postma MJ..
Expert Review of Pharmacoeconomics and Outcomes Research 2021; 21(4): 811-819., 2021.

Health seeking behavior and experiences related to HIV treatment of people living with HIV (PLHIV) in Yangon, Myanmar

Aung HNY, Riewpaiboon A, Sunantiwat M, Hone S, Thavorncharoensap M*..
Pharmaceutical Sciences Asia 2021; 48(4): 320-329., 2021.

Incremental net monetary benefit of bariatric surgery: Systematic review and meta-analysis of cost-effectiveness evidences

Noparatayaporn P, Thavorncharoensap M*, Chaikledkaew U, Bagepally BS, Thakkinstian A..
Obesity Surgery 2021; 31(7): 3279-3290., 2021.

Knowledge, attitude and practice of traditional medicine-related adverse drug reaction (adr) reporting among hospital pharmacists and traditional medicine practitioners in Thailand

Worakunphanich W, Thongsombutpanitch F, Nilsonthi S, Youngkong S, Thavorncharoensap M*..
Pharmaceutical Sciences Asia 2021; 48(4): 330-338., 2021.

Prevalence and factors associated with depression among adult HIV patients attending ART clinics: a cross-sectional study in Western Bhutan

Tshering K*, Suksomboon N, Thavorncharoensap M, Poolsup N..
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV 2021; 33(9): 1139-1145., 2021.

Safety of andrographis paniculata: A systematic review and meta-analysis

Worakunphanich W, Thavorncharoensap M*, Youngkong S, Thadanipon K, Thakkinstian A..
Pharmacoepidemiology and Drug Safety 2021; 30(6): 727-739., 2021.

Statin utilization among patients with acute coronary syndrome: Systematic review

Dewi PEN*, Thavorncharoensap M..
Open Access Macedonian Journal of Medical Sciences 2021; 9(4): 267-278., 2021.

The Cost of locally advanced cervical cancer in Thailand: An empirical study for economic analysis

Katanyoo K, Riewpaiboon A*, Chaikledkaew U, Thavorncharoensap M..
Asian Pacific Journal of Cancer Prevention 2021; 22(10): 3171-3179., 2021.

Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines

Briones JR, Talungchit P, Thavorncharoensap M, Chaikledkaew U*..
BMC health services research 2020; 20(1): 975., 2020.

Economic impact of medical genetic testing on clinical applications in Thailand

Jittikoon J, Sangroongruangsri S, Thavorncharoensap M, Chitpim N, Chaikledkaew U*..
PLoS one 2020; 15(12): e0243934., 2020.

Prevalence and factors associated with depression among adult HIV patients attending ART clinics: a cross-sectional study in Western Bhutan

Tshering K, Suksomboon N, Thavorncharoensap M, Poolsup N..
Frontiers in Plant Science AIDS Care, 2020.

Adding two culture-specific ‘bolt-on’ dimensions on the Thai version of EQ-5D-5L: an exploratory study in patients with diabetes

Kangwanrattanakul K, Gross CR, Sunantiwat M, Thavorncharoensap M*..
Expert Review of Pharmacoeconomics and Outcomes Research 2019;19(3):321-329, 2019.

Cost-effectiveness modelling studies of all preventive measures against rabies: A systematic review

Anothaisintawee T, Julienne Genuino A, Thavorncharoensap M, Youngkong S, Rattanavipapong W, Meeyai A, Chaikledkaew U*..
Vaccine 2019; 37: A146-A153., 2019.

Economic burden of rotavirus diarrhea in Thailand: Report from a pilot study on rotavirus vaccination

Rochanathimoke O, Riewpaiboon A*, Tharmaphornpilas P, Jiamsiri S, Thavorncharoensap M, Postma MJ..
Vaccine 2019; 37(4): 587-594., 2019.

Exploration of a cultural-adaptation of the EQ-5D for Thai population: A “bolt-on” experiment

Kangwanrattanakul K, Gross CR, Sunantiwat M, Thavorncharoensap M*..
Quality of Life Research 2019;28(5):1207-1215, 2019.

Systematic review and meta-analysis of cost-effectiveness of rotavirus vaccine in low-income and lower-middle-income countries

Haider S, Chaikledkaew U*, Thavorncharoensap M, Youngkong S, Islam MA, Thakkinstian A ..
Open Forum Infectious Diseases 2019; 6(4); ofz117., 2019.

The impact of transmission dynamics of rabies control: Systematic review

Rattanavipapong W, Thavorncharoensap M, Youngkong S, Genuino AJ, Anothaisintawee T, Chaikledkaew U, Meeyai A*..
Vaccine 2019; A154-A165., 2019.

Treatment of COPD in one university hospital setting in Thailand: The real-life prescribing patterns and treatment expenditures

Samarnkongsak T, Thavorncharoensap M*, Kawamatawong T, Pattanaprateep O, Chanjaruporn F*, Sunantiwat M*..
Pharmaceutical Sciences Asia 2019; 46(3); 175-183., 2019.

A comparison of EQ-5D-3L index scores using Malaysian, Singaporean, Thai, and UK value sets in Indonesian cervical cancer patients

Endarti D*, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N, Hutubessy R, Kristina SA..
Value in Health Regional Issues 2018; 15: 50-55., 2018.

Adding two culture-specific ‘bolt-on’ dimensions on the Thai version of EQ-5D-5L: an exploratory study in patients with diabetes

Kangwanrattanakul K, Gross CR, Sunantiwat M, Thavorncharoensap M..
Expert Review of Pharmacoeconomics and Outcomes Research 2018; (Article in Press), 2018.

Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions

Nam V.X., Nhung N.V., Hoa N.B., Thuy H.T.T., Phuong N.T.M., Anh N.T., Ngoc Anh L.T., Trung V.Q., Ha T.V., Meeyai A., Thavorncharoensap M., Chaikledkaew U..
International Journal of Tuberculosis and Lung Disease 2018; 22(8): 912-917., 2018.

Economic cost of tobacco-related cancers in Sri Lanka

Amarasinghe H., Ranaweera S., Ranasinghe T., Chandraratne N., Kumara D.R., Thavorncharoensap M., Abeykoon P., De Silva A..
Tobacco Control 2018; 27(5): 542-546., 2018.

Economic costs of alcohol use in Sri Lanka

Ranaweera S, Amarasinghe H, Chandraratne N*, Thavorncharoensap M., Ranasinghe T, Karunaratna S, Kumara D, Santatiwongchai B, Chaikledkaew U, Abeykoon P, De Silva A..
PLoS ONE 2018; 13(6): Art.no.e0198640, 2018.

Health related quality of life impact from rotavirus diarrhea on children and their family caregivers in Thailand

Rochanathimoke O, Riewpaiboon A, Postma MJ, Thinyounyong W, Thavorncharoensap M.*.
Expert Review of Pharmacoeconomics and Outcomes Research 2018; 18(2): 215-222, 2018.

Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand

Siritho S., Thavorncharoensap M., Chanatittarat C., Pasogpakdee P., Apiwattanakul M., Prayoonwiwat N., Chankrachang S., Riewpaiboon A., Chaikledkaew U..
Multiple Sclerosis and Related Disorders 2018; 24: 151-156., 2018.

The EQ-5D-5L Valuation study in Thailand

Pattanaphesaj J., Thavorncharoensap M., Ramos-Goñi J.M., Tongsiri S., Ingsrisawang L., Teerawattananon Y..
Expert Review of Pharmacoeconomics and Outcomes Research 2018; 18(5): 551-558., 2018.

Detection of adverse drug reaction (ADR)-related hospital admissions: A pilot study using administrative database for ADR monitoring in Thailand

Siltharm C, Pattanaprateep O, Pongcharoensuk P, Jeanpeerapong N, Thavorncharoensap M..
Pharmaceutical Sciences Asia 2017; 43(3): 142-153, 2017.

Health seeking behavior and its determinants in Jaffna Sri Lanka

Kalki P, Thavorncharoensap M, Riewpaiboon A*..
Pharmaceutical Sciences Asia 2017; 44(3): 134-141, 2017.

Burden of cancer attributable to tobacco smoking in member countries of the Association of Southeast Asian Nations (ASEAN), 2012

Kristina SA, Endarti D, Thavorncharoensap M*..
Cancer Epidemiology 2016; 44: 84-90., 2016.

Burden of cancers related to smoking among the Indonesian population: Premature mortality costs and years of potential life lost

Kristina S*, Endarti D, Prabandari Y.S., Ahsan A, Thavorncharoensap M..
Asian Pacific Journal of Cancer Prevention 2015; 16(16): 6903-6908, 2015.

Evaluation of Health-Related Quality of Life among Patients with Cervical Cancer in Indonesia

Endarti D*, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N, Hutubessy R, Kristina SA..
Asian Pacific of Journal Cancer Prevention 2015; 16(8): 3345-3350, 2015.

Impact of smoking cessation training for community pharmacists in Indonesia

Kristina SA*, Thavorncharoensap M, Pongcharoensuk P, Prabandari YS..
Asian Pacific Journal of Cancer Prevention 2015; 16(8): 3319-23, 2015.

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients

Pattanaphesaj J, Thavorncharoensap M*..
Health and Quality of Life Outcomes 2015; 13(1): 14, 2015.

Economic costs of obesity in Thailand: A retrospective cost-of-illness study

Pitayatienanan P, Butchon R, Yothasamut J, Aekplakorn W, Teerawattananon Y, Suksomboon N, Thavorncharoensap M*..
BMC Health Services Research 2014; 14:1, 2014.

Effectiveness of Tobacco Education for Pharmacy Students in Indonesia

Kristina SA*, Thavorncharoensap M, Pongcharoensuk P, Montakantikul P, Suansanae T, Prabandari YS..
Asian Pacefic J Cancer Chemprevantion 2014; 15(24): 10783-10786, 2014.

Health-Related Quauity of life in Patients with Cervical Cancer in Indonesia

Endarti D*, Riewpaiboon A, Thavorncharoensap M..
Value in Health 2014; 17(7): 738-739, 2014.

Knowledge, acceptance, and willingness to pay for human papilloma virus (HPV) vaccination among female parents in Thailand

Kruiroongroj S, Chaikledkaew U, Thavorncharoensap M*..
Asian Pacific Journal of Cancer Prevention 2014; 15(13): 5469-5474, 2014.

Measurement of health outcomes.

Thavorncharoensap M..
J Med Assoc Thai. 2014; 97(5) :S27-32., 2014.

Measurement of utility.

Thavorncharoensap M..
J Med Assoc Thai. 2014 ;97(5) :S43-9., 2014.

Pharmacists’ Attitudes toward Role and Perceived Barrier on Smoking Cessation Activities : A Systematic Review

S. A. Kristina*, Thavorncharoensap M..
Mahidol University Journal of Pharmaceutical Sciences 2014; 41 (3): 31-40., 2014.

Quality of Life of Diarrheal Children and Caregivers in Thailand

Rochanathimoke O*, Postma M, Thavorncharoensap M, Riewpaiboon A, Thinyounyong W..
Value in Health 2014; 17(7): 368-369, 2014.

Cost of Adverse Drug Reactions (ADRs) Induced Hospitali-zation: A Systematic Review

Siltharm C, Thavorncharoensap M*..
Mahidol University Journal of Pharmaceutical Sciences 2013; 40 (4), 40-49, 2013.

Efficacy of Varenicline and Nortriptyline in Smoking Cessation: Indirect Comparison of Randomized Controlled Trials

Khairod P, Apichartkulchai S, Chaikledkaew U, Thavorncharoensap M*.
Mahidol University Journal of Pharmaceutical Sciences 2013; 40 (4), 31-39, 2013.

Estimating the willingness to pay for a quality- adjusted life year in Thailand: Does the context of health gain matter?

Thavorncharoensap M*, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P..
ClinicoEconomics and Outcomes Research 2013; 5(1): 29-36, 2013.

Reliability and validity of the Thai version of the Pediatric Quality of Life Inventory 4.0

Sritipsukho P*, Wisai M, Thavorncharoensap M..
Quality of Life Research 2013; 22(3): 551-557, 2013.

ทบทวนการดำเนินการลดการบริโภคเครื่องดื่มแอลกอฮอล์ในประเทศไทย พ.ศ.2540-2550

จอมขวัญ โยธาสมุทร, ศิตาพร ยังคง, ยศ ตีระวัฒนานนท์, มนทรัตม์ ถาวรเจริญทรัพย์, ศรีเพ็ญ ตันติเวสส, อุษา ฉายเกล็ดแก้ว, อดุลย์ โมฮารา, ชนิดา เลิศพิทักษ์พงศ์, อินทิรา ยมาภัย,.
วารสารวิชาการสาธารณสุข. 2011; 5(3): 307-316, 2011.

Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children.

Riewpaiboon A*, Nuchprayoon I, Torcharus K, Indaratna K, Thavorncharoensap M, Ubol BO..
BMC Res Notes 2010; 3:29., 2010.

Factors affecting health-related quality of life in Thai children with thalassemia.

Thavorncharoensap M*, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO..
BMC Blood Disord 2010; 10: 1., 2010.

The economic costs of alcohol consumption in Thailand, 2006

Thavorncharoensap M*, Teerawattananon Y, Yothasamut J, Lertpitakpong C, Thitiboonsuwan K, Neramitpitagkul P, Chaikledkaew U..
BMC Public Health 2010; 10: 323, 2010.

การวิเคราะห์ต้นทุน-ประสิทธิผลของการตรวจคัดกรองพยาธิสภาพจอประสาทตาจากโรคเบาหวานในผู้ป่วยเบาหวาน ชนิดที่ 2

สุภาพร พรพิเนตพงศ์, บุญส่ง องค์พิพัฒน์กุล, ณธร ชัยยาคุณาพฤกษ์, มนทรัตม์ ถาวรเจริญทรัพย์,อัมพร จงเสรีจิตต์.
จักษุเวชสาร 2553; 24(1): 10-25., 2010.

Assessing enforcement of policy on limiting alcohol accessibility and alcohol purchasing. ;

Lertpitakpong C, Teerawattananon Y, Thavorncharoensap M, Thitiboonsuwan K, Yothasamut J, Chaikledkaew U..
J Health Science 2009;18: 537-49., 2009.

Cost of productivity loss due to premature mortality related to alcohol drinking in Thailand.

Lertpitakpong C, Thavorncharoensap M, Neramitpitagkul P,Chaikledkaew U, Teerawattananon Y..
J Health Science 2009:18:3:322-332., 2009.

Economic impact on health care costs related to major diseases including HIV/AIDS due to alcohol drinking among Thai populations

Neramitpitagkul P, Lertpitakpong C, Yothasamut J, Thavorncharoensap M, Chaikledkaew U*, Teerawattananon Y..
Value Health 2009; 12(Sp.lss.2 Suppl.3): S97-S100., 2009.

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders

Rehm J*, Mathers C, Patra J, Popova S, Thavorncharoensap M, Teerawattanaon Y..
The Lancet 2009; 373(9682): 2223-2233., 2009.

Provider-initiated HIV/AIDS counseling and testing at healthcare facilities in Thailand: a cluster-randomisation trial

Teerawattananon Y, Leelukkanaveera Y, Thavorncharoensap M, Hanvoravongchai P, Ingsrisawang L, Tantives S, Chaikledkaew U, Mohara A, Lertpiriyasuwat C, Pimsawan N.
Journal of development effectiveness 2009:1(4):450-469., 2009.

The Economic impact of alcohol consumption: A systematic review

Thavorncharoensap M*, Teerawattananon Y, Yothasamut J, Lertpitakpong C, Chaikledkaew U..
Subst Abuse Treat Prev Policy 2009; 4: 20, 2009.

The current capacity and future development of economic evaluation for policy decision making: a survey among researchers and decision makers in Thailand

Chaikledkaew U*, Lertpitakpong C, Teerawattananon Y, Thavorncharoensap M, Tangcharoensathien V..
Value Health 2009; 12(Sp.Iss.2 Suppl.3): S31-S35., 2009.

ต้นทุนทางเศรษฐศาสตร์ของการขาดงานและด้อยประสิทธิภาพการทำงานจากการบริโภคแอลกอฮอล์

กรรณิการ์ ฐิติบุญสุวรรณ, มนทรัตม์ ถาวรเจริญทรัพย์, ชนิดา เลิศพิทักษ์พงษ์, จอมขวัญ โยธาสมุทร, อุษา ฉายเกล็ดแก้ว, ยศ ตีระวัฒนานนท์.
วารสารวิจัยระบบสาธารณสุข 2552; 3(1): 102-112, 2009.

A Measurement of clinical effects.

Teerawattananon Y, Thavorncharoensap M, Mohara M..
J Med Assoc Thai. 2008;91(Suppl 2):S38-42., 2008.

A determination of topics for health technology assessment in Thailand: making decision makers involved

Lertpitakpong C, Chaikledkaew U, Thavorncharoensap M, Tantivess S, Praditsitthikorn N, Youngkogn S, Yothasamut J, Udomsuk K, Sinthitichai K, Teerawattananon Y.
J Med Assoc Thai 2008;91(Suppl 2):S100-9., 2008.

Making health technology assessment information available for decision making: the development of a Thai database.

Kapol N, Maitreemit P, Chalongsuk R, Amrumpai Y, Sribundit N, Thavorncharoensap M, Chaikledkaew U, Teerawattananon Y..
J Med Assoc Thai 2008;91(Suppl 2):S8-10, 2008.

การคัดเลือกหัวข้อสำหรับการประเมินเทคโนโลยีและนโยบายด้านสุขภาพในประเทศ: กรณีศึกษาการมีส่วนร่วมโดยผู้กำหนดนโยบาย

ชนิดา เลิศพิทักษ์พงศ์, อุษา ฉายเกล็ดแก้ว, มนทรัตม์ ถาวรเจริญทรัพย์, ศรีเพ็ญ ตันติเวสส, นัยนา ประดิษฐ์สิทธิกร, ศิตาพร ยังคง, จอมขวัญ โยธาสมุทร, กาญจนาถ อุดมสุข, กงกช สินธิติชัย, ยศ ตีระวัฒนานนท์.
วารสารวิชาการสาธารณสุข 2551;17(4), 2008.

การสำรวจการยอมรับและความคิดเห็นของเภสัชกรต่อการศึกษาต่อเนื่องทางเภสัชศาสตร์

มนทรัตม์ ถาวรเจริญทรัพย์ ปรีชา มนทกานติกุล พัชราภรณ์ เยี่ยมสวัสดิ์ วีนัส ขุติมานิตสกุล.
วารสารเภสัชกรรมโรงพยาบาล 2547; 14(3): 225-233, 2004.

Development of a bolt-on version of the EQ-5D-5L questionnaire for use in Thai populartion.

Kangwanrattanakul K, Sunanthihiwat M, Thavorncharoensap M*..
5th HTAsiaLink Annual Conference. 4-6 May 2016 2016;, 2016.

Anti-emetic prophylaxis medication pattern for chemotherapy induced nausea vomiting (CINV) in patients with solid tumor at rajavithi hospital

Wisit K*, Tanyasaensook K, Thavorncharoensap M, Maneechavakajorn J, Chiaovit J..
Proceedings of The 2nd ASEAN Plus Three Graduate Research Congress Bangkok, Thailand 5-7 February 2014 , 2014.

Factor influencing physician’s decision on generic drug prescription: a case study of statin

Rodvanna P*, Anothaisintawee T, Youngkong S, Thavorncharoensap M..
Mahidol University Research Expo 2014 "MU Look to the Future" 1st - 2nd December 2014 , 2014.

Utilty measure among hearing impaired patients.

Rodvanna P*, Thavorncharoensap M..
Pharma Indochina VIII ASEAN Pharmacy - Integration for Development, Vietnam. on 4-5 December 2013 , 2013.

Health related quality of life (HRQOL) in Thai diabetic patients.

Thavorncharoensap M., Pongcharoensuk P., Chaikledkaew U., Suksomboon N. .
the ISPOR 2nd Asia Pacific conference 5-7 March 2006, Shanghai,, 2009.

Review of alcohol consumption trend, alcohol policies and contributions from key players in reducing alcohol consumption between 1997-2007 in Thailand.

Youngkong S, Yothasamut J, Teerawattananon Y, Thavorncharoensap M..
The ISPOR 3rd Asia Pacific conference, September 7-9, 2008, Seoul, Korea. 7-9 September 2008, Seoul, Korea., 2008.

Diabetic retinopathy modeling: A cost-effectiveness of varying screening intervals in type-2 diabetes mellitus in Thailand

Pornpinatepong S, Chaiyakunapruk N, Thavorncharoensap M..
ISPOR 10th Annual International Meeting,. Washington D.C., USA. 2005, 2005.

การวัดผลงานบริการจ่ายยาผู้ป่วยนอกโรงพยาบาลสมเด็จพระปิ่นเกล้า

จันทนา ปัญญาสาธิตกิจ, กฤติยา นุราช, วิสิฎฐ์ศรี เพิ่มสุขจิตต์, มนทรัตม์ ถาวรเจริญทรัพย์..
ประชุมใหญ่สามัญประจำปี 2547 สมาคมเภสัชกรรมโรงพยาบาลแห่งประเทศไทย 2004, 2004.